Skip to content

EV / EBITDA at other companies

Universal Health Services logo
Universal Health ServicesUHS
-1.4×
Healthpeak Properties logo
Healthpeak PropertiesDOC
5.8×-2.6×
Welltower logo
WelltowerWELL
33×+4.6×
American Healthcare REIT logo
American Healthcare REITAHR
26.5×+2.9×
Empire State Realty Trust logo
Empire State Realty TrustESRT
9.9×-0.1×
American Assets Trust logo
American Assets TrustAAT
4.5×+0.8×

Other financials

Income statement

See full
Revenue$24.5M-0.1%
Operating income$9.0M-0.9%
Net income$5.0M+5.1%
EPS (diluted)$0.36+5.9%

Balance sheet

See full
Cash & equivalents$7.1M+1.3%
Total debt$11.4M+4.5%
Total equity$147.8M-14.2%
Total assets$563.8M-1.7%

Cash flow

See full
Operating cash flow$12.0M+2.9%
CapEx$22.0K
Free cash flow$10.4M-15.1%

Valuation

See full
Market cap$579.17M+0.7%
Enterprise value$583.5M+0.8%
P/E32.4×+1.7×
P/S5.8×0.0×

Profitability

See full
Operating margin35%-2.0pp
Net margin18%-1.0pp
FCF margin36.6%

Returns & leverage

See full
Return on equity11.2%+1.0pp
Debt / equity0.1×0.0×

Where this comes from

Calculated from Universal Health Realty’s reported figures.

Based on the most recent quarter.

The official record: Universal Health Realty’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Universal Health Realty's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Universal Health Realty's EV / EBITDA?
Universal Health Realty (UHT) reported EV / EBITDA of 8.9× in Q1 2026.
How has Universal Health Realty's EV / EBITDA changed year-over-year?
Universal Health Realty's EV / EBITDA decreased by 0.7% year-over-year, from 9× to 8.9×.
What is the long-term trend for Universal Health Realty's EV / EBITDA?
Over 5 years (2020 to 2025), Universal Health Realty's EV / EBITDA has grown at a -12.9% compound annual growth rate (CAGR), from 17.2× to 8.6×.
What does EV / EBITDA mean?
Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.